Purchases and Sales Made in Q4 2022 in Sage Therapeutics, Inc. (SAGE)
This table provides information about the institutional ownership of Sage Therapeutics, Inc. (SAGE) during Q4 2022. The information is specifically focused on institutions that hold shares of Sage Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Prelude Capital Management, LLC
New York, NY |
SELL
|
- |
-13.1K- 52.12% |
$421K - $571K
|
12K
$65.9K
|
|
|
Feb 13, 2023
Q4 2022
|
Primecap Management CO
Pasadena, CA |
SELL
|
- |
-13.2K- 16.97% |
$425K - $576K
|
64.6K
$354K
|
|
|
Feb 14, 2023
Q4 2022
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-14.8K- 56.08% |
$477K - $646K
|
11.6K
$63.6K
|
|
|
Feb 14, 2023
Q4 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-25.5K- 13.93% |
$821K - $1.11M
|
158K
$863K
|
|
|
Feb 14, 2023
Q4 2022
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-29.3K- 21.84% |
$944K - $1.28M
|
105K
$575K
|
|
|
Feb 13, 2023
Q4 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-30.9K- 5.54% |
$997K - $1.35M
|
528K
$2.89M
|
|
|
Feb 13, 2023
Q4 2022
|
Finepoint Capital LP
Boston, MA |
SELL
|
- |
-47.5K- 11.08% |
$1.53M - $2.07M
|
382K
$2.09M
|
|
|
Feb 13, 2023
Q4 2022
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-55.1K- 79.61% |
$1.77M - $2.4M
|
14.1K
$77.4K
|
|
|
Feb 14, 2023
Q4 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-69.7K- 6.96% |
$2.25M - $3.04M
|
933K
$5.11M
|
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-78.8K- 51.73% |
$2.54M - $3.43M
|
73.5K
$403K
|
|
|
Feb 14, 2023
Q4 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-90K- 57.03% |
$2.9M - $3.92M
|
67.8K
$372K
|
|
|
Feb 14, 2023
Q4 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-110K- 80.35% |
$3.54M - $4.8M
|
26.9K
$147K
|
|
|
Feb 14, 2023
Q4 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-112K- 15.97% |
$3.61M - $4.89M
|
589K
$3.23M
|
|
|
Feb 14, 2023
Q4 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-112K- 15.33% |
$3.61M - $4.89M
|
619K
$3.39M
|
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-116K- 7.58% |
$3.73M - $5.06M
|
1.41M
$7.74M
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-123K- 75.43% |
$3.96M - $5.37M
|
40.1K
$220K
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-165K- 14.88% |
$5.33M - $7.21M
|
946K
$5.18M
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-165K- 14.88% |
$5.33M - $7.21M
|
946K
$5.18M
|
|
|
Feb 14, 2023
Q4 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-227K- 7.7% |
$7.32M - $9.92M
|
2.73M
$14.9M
|
|
|
Feb 14, 2023
Q4 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-243K- 11.36% |
$7.83M - $10.6M
|
1.9M
$10.4M
|